Skip to content

Video Consent Form Versus Written Consent Form for ERCP

Combination of Video and Written Information Provides the Patient With a More Comprehensive Level of Knowledge About Endoscopic Retrograde Cholangiopancreatography: Study Protocol for Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02810379
Enrollment
120
Registered
2016-06-23
Start date
2016-01-31
Completion date
Unknown
Last updated
2016-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Consent Forms of ERCP

Keywords

informed consent, ERCP, video

Brief summary

To prove that video about endoscopic retrograde cholangiopancreatography (ERCP) combined with written informed consent provides participants more information about the procedure, which can make participants understand the procedure well. Investigators advocate the development of institutional and national guidelines to ensure optimal practices of acquiring informed consent.

Interventions

PROCEDUREvideo+written informed consent

Sponsors

Changhai Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* All inpatients who will receive ERCP

Exclusion criteria

* under 18 years or more than 70 years * pregnancy or breast-feeding women * circulatory and respiratory disorders * mental illness

Design outcomes

Primary

MeasureTime frame
time for informed consent practices before ERCP2 days
time for extra explanation about ERCP2 days

Secondary

MeasureTime frame
satisfaction degree about the informed consent practices2 days

Other

MeasureTime frame
anxiety level after the informed consent practices2 days

Countries

China

Contacts

Primary ContactZhaoshen Li, MD
zhaoshenlismmu@gmail.com+86-21-25070552
Backup ContactYu Bai, MD
baiyu1998@hotmail.com+86-13564665324

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026